Sponsored by Ionis Pharmaceuticals, the FCS Genetic Testing program from Prevention Genetics is available to certain qualifying patients who have:
- Extremely high triglyceride levels (> 880 mg/dL or > 10 mmol/L) on two fasting blood tests in a row.
- No other known causes of high TG levels.
As part of the program’s partnership, an independent genetic counseling service, Genome Medical, can provide information on FCS and support during the genetic testing process
Call +1 888.478.1494 to learn more.
Genome Medical has teamed up with Arrowhead Pharmaceuticals and Ambry Genetics to provide a sponsored, no-cost genetic testing program for patients who have a clinical history of severe hypertriglyceridemia. Patients who are eligible for this program may have an underlying genetic cause of their complications, such as Familial Chylomicronemia Syndrome or hyperlipoproteinemia.
Program Eligibility
Ambry Genetics’ HTG-Select panel is a 6-gene test aimed at identifying the underlying genetic cause of hypertriglyceridemia in eligible patients. This includes disorders such as Familial Chylomicronemia Syndrome (FCS) or other clinically associated conditions. This program is available to individuals with all the following:
- 17 years of age and older
- Fasting triglyceride level of >750 mg/dL [> 8.48 mmol/L] in the past 12 months
- No Prior genetic testing for FCS
Call +1 877.688.0992 to learn more.